Project Details
Project Description
John Reynolds' services in the Role of Trial Statistician for the Study
| Short title | ALLG CML13 |
|---|---|
| Status | Active |
| Effective start/end date | 1/12/20 → 1/12/25 |
An ALLG single arm phase II study to evaluate the efficacy of asciminib in newly diagnosed patients with chronic phase chronic myeloid leukaemia
- Reynolds, John (Primary Chief Investigator (PCI))
Project: Research